80,95 €
80,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
40 °P sammeln
80,95 €
80,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
40 °P sammeln
Als Download kaufen
80,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
40 °P sammeln
Jetzt verschenken
80,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
40 °P sammeln
  • Format: ePub

Survival of patients with metastatic cancer has increased over the past two decades as a result of a progressive improvement of regional and systemic therapies. However, oncologists' estimates of patients' predicted overall survival in metastatic cancer are imprecise. The purpose of this book is to systematize the evidence regarding the prognostic factors of metastatic gastrointestinal tumors, separating the findings with the highest level of evidence among those available for each disease by selecting studies with the highest scientific evidence level.

Produktbeschreibung
Survival of patients with metastatic cancer has increased over the past two decades as a result of a progressive improvement of regional and systemic therapies. However, oncologists' estimates of patients' predicted overall survival in metastatic cancer are imprecise. The purpose of this book is to systematize the evidence regarding the prognostic factors of metastatic gastrointestinal tumors, separating the findings with the highest level of evidence among those available for each disease by selecting studies with the highest scientific evidence level.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Giuseppe A. Colloca, MD, Oncologia Medica & Innovation, Imperia, Italy

Antonella Venturino, MD, Oncologia Medica & Innovation, Imperia, Italy